Mississippi Healthcare Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mississippi Healthcare Reporter.

Press releases published on September 16, 2026

an hour ago

Abalos Therapeutics Publishes Two Articles in Viruses Further Validating its AdaptInnate Approach to Treat Solid Tumors

Indeterminate GlobeNewswire

2 hours ago

Theolytics to Showcase its Innovative Oncolytic Immunotherapy Strategy – including THEO-260 in Advanced Ovarian Cancer – at Upcoming Investor and Scientific Events

Indeterminate GlobeNewswire

3 hours ago

EIB and Angelini Ventures’ Partnership Reaches €48.5 Million in Investments

Indeterminate GlobeNewswire

3 hours ago

UpFront Diagnostics Announces CE Mark Approval for LVOne — the World's First Rapid Blood Test to Diagnose Stroke

Indeterminate GlobeNewswire

3 hours ago

UpFront Diagnostics erhält CE-Zulassung für LVOne – weltweit erster Blut-Schnelltest zur Schlaganfalldiagnose

Indeterminate GlobeNewswire

3 hours ago

UpFront Diagnostics obtient le marquage CE pour LVOne, premier test sanguin rapide au monde destiné au diagnostic de l’AVC

Indeterminate GlobeNewswire

3 hours ago

EURETINA: PulseSight Therapeutics to Present Results of Phase 1 clinical trial of PST-611 treatment for dry AMD/Geographic Atrophy (GA)

Indeterminate GlobeNewswire

4 hours ago

RIX Industries Partners with Build Health International to Bring Medical Oxygen Compressor Training to Africa

Indeterminate GlobeNewswire

4 hours ago

LEQEMBI® Pen (Subcutaneous Formulation of LEQEMBI®) Approved in Japan for the Treatment of Early Alzheimer’s Disease

Indeterminate GlobeNewswire

4 hours ago

חברת RIX Industries משתפת פעולה עם Build Health International כדי להביא לאפריקה הכשרה בנושא מדחסי חמצן רפואיים

Indeterminate GlobeNewswire

5 hours ago

Nicox : Les données sur NCX 470 seront présentées lors du Congrès annuel 2026 de l’AAOpt

Indeterminate GlobeNewswire

5 hours ago

Data on Nicox's NCX 470 to be presented at AAOpt Annual Meeting 2026

Indeterminate GlobeNewswire

6 hours ago

Cambium Bio Secures A$10.85 Million to Initiate Pivotal Phase 3 Trial of Elate Ocular®, a Potential First-in-Class Biologic for Dry Eye Disease

Indeterminate GlobeNewswire

6 hours ago

Beta Bionics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

Indeterminate GlobeNewswire